# Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

> **NCT05718544** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 199 (actual)

## Conditions studied

- Scoliosis Correction
- Postoperative Analgesia
- Esketamine
- Dexmedetomidine
- Chronic Postsurgical Pain

## Interventions

- **DRUG:** Esketamine
- **DRUG:** Dexmedetomidine
- **DRUG:** Sufentanil

## Key facts

- **NCT ID:** NCT05718544
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-30
- **Primary completion:** 2023-09-07
- **Final completion:** 2023-09-07
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05718544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05718544, "Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05718544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*